Cite
HARVARD Citation
Bernard, K. et al. (2019). A 24‐week double‐blind placebo‐controlled study of the efficacy and safety of the AMPA modulator S47445 in patients with mild to moderate Alzheimer's disease and depressive symptoms. Alzheimer's & dementia. 5 (1), pp. 231-240. [Online].